These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2680618)

  • 1. Validity of the Bioself 110 fertility indicator.
    Labrecque M; Drouin J; Rioux JE; Gingras S; Spieler JM
    Fertil Steril; 1989 Oct; 52(4):604-8. PubMed ID: 2680618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of the BIOSELF 110 fertility indicator.
    Ismail M; Arshat H; Pulcrano J; Royston P; Spieler J
    Contraception; 1989 Jan; 39(1):53-71. PubMed ID: 2642781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of the Bioself 110 electronic fertility indicator as a contraceptive aid.
    Flynn A; Pulcrano J; Royston P; Spieler J
    Contraception; 1991 Aug; 44(2):125-39. PubMed ID: 1893707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contraceptive application of the Bioself fertility indicator.
    Drouin J; Guilbert EE; Désaulniers G
    Contraception; 1994 Sep; 50(3):229-38. PubMed ID: 7805373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CUE Fertility Monitor compared to ultrasound and LH peak measurements for fertile time ovulation detection.
    Freundl G; Bremme M; Frank-Herrmann P; Baur S; Godehardt E; Sottong U
    Adv Contracept; 1996 Jun; 12(2):111-21. PubMed ID: 8863906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Salivary LH as an ovulation indicator: on the value of autopalpation of the cervix uteri for the detection of fertile and infertile days of the cycle].
    Loewit K; Wolfram G; Ortlieb A; Widhalm R
    Geburtshilfe Frauenheilkd; 1987 Nov; 47(11):803-7. PubMed ID: 3692114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inaccuracy of basal body temperature charts in predicting urinary luteinizing hormone surges.
    Quagliarello J; Arny M
    Fertil Steril; 1986 Mar; 45(3):334-7. PubMed ID: 3949032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the ovulation method with the CUE ovulation predictor in determining the fertile period.
    Fehring RJ
    J Am Acad Nurse Pract; 1996 Oct; 8(10):461-6. PubMed ID: 9305046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personal hormone monitoring for contraception.
    Bonnar J; Flynn A; Freundl G; Kirkman R; Royston R; Snowden R
    Br J Fam Plann; 1999 Jan; 24(4):128-34. PubMed ID: 10023097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimated maximum failure rates of cycle monitors using daily conception probabilities in the menstrual cycle.
    Freundl G; Godehardt E; Kern PA; Frank-Herrmann P; Koubenec HJ; Gnoth Ch
    Hum Reprod; 2003 Dec; 18(12):2628-33. PubMed ID: 14645183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring techniques to predict and detect ovulation.
    Vermesh M; Kletzky OA; Davajan V; Israel R
    Fertil Steril; 1987 Feb; 47(2):259-64. PubMed ID: 3817171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of ovulation by urinary hormone measurements with the home use ClearPlan Fertility Monitor: comparison with transvaginal ultrasound scans and serum hormone measurements.
    Behre HM; Kuhlage J; Gassner C; Sonntag B; Schem C; Schneider HP; Nieschlag E
    Hum Reprod; 2000 Dec; 15(12):2478-82. PubMed ID: 11098014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability in the hormonally estimated fertile phase of the menstrual cycle.
    Fehring RJ; Schneider M
    Fertil Steril; 2008 Oct; 90(4):1232-5. PubMed ID: 18249381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of perception of ovulation day in women trying to conceive.
    Zinaman M; Johnson S; Ellis J; Ledger W
    Curr Med Res Opin; 2012 May; 28(5):749-54. PubMed ID: 22462529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early luteal phase treatment with mifepristone (RU 486) for fertility regulation.
    Gemzell-Danielsson K; Swahn ML; Svalander P; Bygdeman M
    Hum Reprod; 1993 Jun; 8(6):870-3. PubMed ID: 8345076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standardized protocols for characterizing women's fertility: A data-driven approach.
    Blake KR; Dixson BJ; O'Dean SM; Denson TF
    Horm Behav; 2016 May; 81():74-83. PubMed ID: 27072982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the OvuSTICK urinary luteinizing hormone kit in normal and stimulated menstrual cycles.
    Elkind-Hirsch K; Goldzieher JW; Gibbons WE; Besch PK
    Obstet Gynecol; 1986 Mar; 67(3):450-3. PubMed ID: 3511422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability in the phases of the menstrual cycle.
    Fehring RJ; Schneider M; Raviele K
    J Obstet Gynecol Neonatal Nurs; 2006; 35(3):376-84. PubMed ID: 16700687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The risks of the natural family planning methods].
    Zufferey MM
    Ther Umsch; 1986 May; 43(5):417-24. PubMed ID: 3726778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and prediction of the fertile window with a new web-based medical device using a vaginal biosensor for measuring the circadian and circamensual core body temperature.
    Regidor PA; Kaczmarczyk M; Schiweck E; Goeckenjan-Festag M; Alexander H
    Gynecol Endocrinol; 2018 Mar; 34(3):256-260. PubMed ID: 29082805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.